Drugdrug interactions and their potential impact on toxicity levels in patients with b-cell malignancy
Ral Crdoba, MD, PhD, of University Hospital Infanta Sofa, Madrid, Spain, discusses results from a drugdrug interaction study (NCT02381080) of ibrutinib with moderate and strong cytochrome p3a (CYP...
Author: VJHemOnc
Added: 01/04/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts